Health in Mozambique 1,308 indicators covering health for Mozambique. IndicatorLatest Year10-yr change Rank Inflation-adjusted prices for most sold brand of cigarettes: Price in 90 2022 up 88.2% 77th Estimated number of children needing antiretroviral therapy based on 160,000 2025 down 15.8% 1st Weight-for-height <-3 SD 0.7284 2022 down 69.4% 56th Prevalence of severe wasting, weight for height 0.7% 2022 down 70.8% 56th Physical activity policies for activie societies 20 2023 up 100.0% 2nd Physical activity policies focused on active systems 20 2023 unchanged 5th Midwifery personnel 11,017 2024 up 137.0% 27th Number of deaths from malaria who 17,946 2024 down 22.6% 7th Death rate from malaria 51.82 2024 down 42.4% 14th Incidence of malaria 295.1 2024 down 18.4% 8th Share of one year olds who received the final dose of pneumococcal vac 55 2024 down 27.6% 137th Diphtheria tetanus pertussis vaccine vs pneumococcal vaccine coverage 55 2024 down 27.6% 137th Estimated antiretroviral therapy coverage among children 61 2025 up 74.3% 30th Death rate from poisonings 1.5 2021 unchanged 23rd 3.8.1 Coverage of essential health services 44 2021 up 41.9% 165th Mortality rate attributed to cardiovascular disease, cancer, diabetes 26.6 2021 down 4.7% 17th Mortality rate attributed to unintentional poisonings, by sex 1.5 2021 unchanged 22nd Suicide mortality rate, by sex 10.6 2021 up 16.5% 49th Rotavirus number unvaccinated 464,625 2023 down 42.4% 11th Prevalence of stunting, height for age 36.7% 2022 down 14.5% 12th Affordability - percentage of GDP per capita required to purchase 25.84 2022 up 92.8% 3rd Japanese encephalitis - number of reported cases 0 2019 — 19th Malaria cases reported 11.61 million 2024 up 56.8% 3rd Deaths and missing persons due to natural disasters 60.02 2022 up 49,916.7% 5th Mean systolic blood pressure 132.3 2009 up 2.6% 13th Mean fasting blood glucose (mmol/l) 5.1 2009 unchanged 146th Number of pregnant women living with HIV who received antiretrovirals 107,820 2025 up 8.0% 2nd Hiv expenditure 557.78 million 2019 up 280.9% 7th Number of new leprosy cases with G2D among children 17 2024 up 6.2% 6th Neonates protected at birth against neonatal tetanus (PAB) 84.0% 2022 up 1.2% 73rd Prevalence of overweight, weight for height 3.2% 2022 down 59.0% 67th Most sold brand of cigarettes - price in currency reported 60 2020 up 200.0% 84th Most sold brand of cigarettes - taxes as a % of price - total tax 0.3% 2020 up 7.4% 153rd Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.0% 2020 — 109th Most sold brand of cigarettes - taxes as a % of price - import duties 0.0% 2020 — 34th Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 — 42nd Most sold brand of cigarettes - taxes as a % of price - value added 0.1% 2020 unchanged 48th Most sold brand of cigarettes - taxes as a % of price - specific 0.1% 2020 up 16.7% 110th Most sold brand of cigarettes - price in US$ at official exchange 0.85 2020 up 57.4% 171st Number healthy diet unaffordable 30.90 million 2024 up 29.8% 16th Import of environmentally sound technologies 474.99 million 2020 up 145.6% 99th Percentage of people living with HIV who know their HIV status 90 2025 up 45.2% 49th Percentage of people living with HIV who know their status receiving 93 2025 up 43.1% 53rd Most sold brand of cigarettes - price in PPP$ 2.46 2020 up 105.0% 155th Export of environmentally sound technologies 8.37 million 2020 down 29.3% 128th Pcv3 number unvaccinated 522,703 2023 up 1.6% 13th Reported number of human rabies deaths 35 2024 up 20.7% 14th Proportion of births delivered in a health facility (Facility births) 64.6% 2023 down 6.2% 117th Number of non-autochthonous leprosy cases 0 2024 — 47th Estimated number of children (aged 0-17 years) who have lost one or 1.20 million 2024 up 5.3% 2nd Prevalence of wasting, weight for height, female 3.2% 2022 down 42.9% 51st Prevalence of wasting, weight for height, male 4.4% 2022 down 34.3% 44th Number reported cases of cholera 5,072 2021 up 296.6% 5th Population with basic handwashing facilities at home 9.9% 2024 up 21.7% 105th Prevalence of severe wasting, weight for height, female 0.6% 2022 down 68.4% 54th Prevalence of severe wasting, weight for height, male 0.9% 2022 down 67.9% 50th Prevalence of overweight, weight for height, female 3.1% 2022 down 59.2% 57th Prevalence of overweight, weight for height, male 3.2% 2022 down 60.5% 58th HPV immunization coverage estimates among primary target cohort (9-14) 74.0% 2025 — 53rd Prevalence of underweight, weight for age, female 13.5% 2022 down 0.7% 30th ← Previous Page 18 of 22 Next →